Nonoccupational post-exposure prophylaxis source tracing: is it really feasible in Australia?

Pierce, A B; Armishaw, J; Price, B; Wright, E J; Dax, E M; Fairley, C K; Hoy, J F

Pierce, A B; Armishaw, J; Price, B; Wright, E J; Dax, E M; Fairley, C K; Hoy, J F.

Affiliation

Pierce AB; Victorian NPEP Service, Infectious Diseases Unit, The Alfred Hospital, Melbourne, Vic, Australia.

HIV Med ; 13(7): 436-8, 2012 Aug.

Article in En | MEDLINE | ID: mdl-22276852

Subject(s)

Anti-HIV Agents/supply & distribution; Contact Tracing/methods; Drug Prescriptions/statistics & numerical data; HIV Seropositivity/diagnosis; Post-Exposure Prophylaxis/supply & distribution; Anti-HIV Agents/economics; Anti-HIV Agents/therapeutic use; Australia/epidemiology; Contact Tracing/economics; Cost-Benefit Analysis; Feasibility Studies; Female; HIV Seropositivity/drug therapy; HIV Seropositivity/economics; HIV Seropositivity/epidemiology; Humans; Male; Patient Selection; Post-Exposure Prophylaxis/economics; Sexual Partners; Switzerland/epidemiology; Victoria/epidemiology

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Drug Prescriptions / Contact Tracing / HIV Seropositivity / Anti-HIV Agents / Post-Exposure Prophylaxis Limits: Female / Humans / Male Country/Region as subject: Europa / Oceania Language: En Year: 2012 Type: Article

Fulltext

XML

PubMed Links

Search on Google